Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. CCHGY
9. PRY:IM
10. PRYMY

Go back to Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update

Achieve Life Sciences (ACHV) Misses Q1 EPS by 25c

May 15, 2019 4:20 PM EDT

Achieve Life Sciences (NASDAQ: ACHV) reported Q1 EPS of ($0.88), $0.25 worse than the analyst estimate of ($0.63).

Rick Stewart, Chairman and Chief Executive Officer of Achieve Life Sciences commented, "With the results of the ORCA-1 trial expected by the end of the second quarter, we are... More